Latest Breaking News On - இருதய மையம் - Page 7 : comparemela.com

(1) LAGUNA HILLS, Calif., July 7, 2021 /PRNewswire/ Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), today announced successful first-in-human use of ultra-low temperature cryoablation (ULTC) for the treatment of monomorphic VT. The two-hour mapping and ablation procedure was performed by Dr. Tom De Potter, MD, Associate Director, Cardiovascular Center Department of Cardiology, Electrophysiology Section at the Cardiovascular Center OLV Hospital, Aalst, Belgium. Procedural success was ascertained by the lack of the inducible arrhythmia after a set of ULTC lesions was delivered to isolate inferior-posterior ischemic scar in patient s left ventricle. No procedural complications were observed, and patient remained arrhythmia-free through the first 30 days of the follow-up.

United statesLaguna hillsRegion flamandeNoord hollandKostenloser wertpapierhandelOlav bergheimLucas boersmaCardiovascular center department of cardiologyAdagio medical incPrnewswire adagio medical incCardiovascular centerTom de potterAssociate directorCardiovascular center departmentElectrophysiology sectionProfessor lucas boersma